|Articles|May 15, 2014
- Pharmaceutical Technology-05-15-2014
- Volume 2014 eBook
- Issue 2
Potential Benefits Drive Interest in Continuous Manufacturing
Author(s)Cynthia A. Challener
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Advertisement
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Download
.
Articles in this issue
over 12 years ago
Continuous Bioprocessing Challengesover 12 years ago
Optimizing the Sterilization of Liquids in Sealed Containersover 12 years ago
Using Modular Systems in Biopharmaceutical Manufacturingover 12 years ago
Determining Protein Oxidation Induced During Fill-Finish Operationsover 12 years ago
Single-Use Technology in Parenteral Fill/FinishAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma's Next AI Problem Is Authority
2
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
3
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
4
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
5